Premium
AUGMENTATION STRATEGIES FOR TREATMENT‐RESISTANT ANXIETY DISORDERS: A SYSTEMATIC REVIEW AND META‐ANALYSIS
Author(s) -
Patterson Beth,
Van Ameringen Michael
Publication year - 2016
Publication title -
depression and anxiety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.634
H-Index - 129
eISSN - 1520-6394
pISSN - 1091-4269
DOI - 10.1002/da.22525
Subject(s) - meta analysis , anxiety , placebo , panic disorder , adverse effect , subgroup analysis , medicine , social anxiety , agoraphobia , randomized controlled trial , clinical global impression , psychiatry , clinical psychology , alternative medicine , pathology
Background A systematic review and meta‐analysis was conducted to explore the efficacy of medication augmentation strategies compared to control treatments in patients who have had a partial or no response to initial treatment for generalized anxiety disorder, social anxiety disorder, and panic disorder. Methods Double‐blind controlled trials of medication augmentation in adult treatment‐resistant anxiety disorders conducted between January 1990 and January 2015 were systematically reviewed and evaluated by two independent raters. The search identified 625 articles; 610 were excluded following abstract review and 15 had full‐text screening. Studies had to include a definition of treatment resistance, exclude concomitant medications, and have a parallel or crossover design. Data extraction forms were completed in duplicate. Results Six studies were included in the meta‐analysis. Effect estimates were calculated using random effects modeling; heterogeneity was assessed and subgroup and sensitivity analyses were completed. Primary outcome was response, defined by Clinical Global Impression–Improvement score of ≤2. Augmentation was not associated with an increased risk of response, as compared with placebo ( RR = 1.08, 95% CI = 0.94–1.24). A small significant effect was found in reduction in symptom severity: standard mean difference = –0.32, 95% CI = –0.56 to –0.08. No significant differences between augmentation with medication versus placebo were found in ratings of functional impairment and dropouts due to adverse events. Conclusions Augmentation does not appear to be beneficial in treatment‐resistant anxiety disorders. These results may be limited by small study samples, and a small number of overall studies in the analysis.